Evidence-based resources empowering caregivers, families, and communities navigating Alzheimer's disease and related dementias.
By Dr. Sherry L. Perry, PhD — Social & I/O Psychologist
Select a stage to learn what to expect.
No noticeable symptoms. Brain changes may already be occurring at a cellular level. This stage can last years or even decades before any signs appear.
Minor memory lapses that may seem like normal age-related forgetfulness — misplacing keys, forgetting familiar names. Not yet detectable during medical examinations.
Friends and family begin to notice difficulties. Problems with word-finding, planning, organizing, and remembering names of new acquaintances.
Clear cognitive deficits emerge. Difficulty with arithmetic, managing finances, forgetting personal history. The individual may become withdrawn in social situations. Typically lasts about two years.
Significant memory and cognitive gaps. Assistance needed for many daily activities, though they can generally still eat and use the toilet independently. Confusion about time and place is common.
Memory declines significantly. Personality and behavior changes become pronounced. Extensive help needed for daily activities. May not recognize familiar faces.
The final stage. Loss of ability to respond to the environment or carry on conversation. Total care is needed. The body's systems gradually shut down.
Alzheimer's disease disproportionately impacts communities of color.
Approximately twice as likely to develop Alzheimer's or other dementias compared to non-Hispanic White Americans, driven by cardiovascular risk factors, systemic healthcare inequities, and underrepresentation in clinical research.
About 1.5 times more likely to develop Alzheimer's, compounded by higher diabetes prevalence, language barriers, cultural stigma, and limited access to culturally appropriate resources.
Fewer specialists in underserved communities, cognitive tests that lack cultural validation, and symptoms dismissed as "normal aging" all delay timely diagnosis and treatment for communities of color.
Caregivers of color are more likely to provide high-intensity care, less likely to use formal support services, and face higher rates of burnout and financial strain.
Increased confusion and agitation that occurs in late afternoon and evening. Select a topic to learn more.
You cannot pour from an empty cup. Taking care of yourself is essential.
Trusted organizations and services to support you on this journey.
Click any medication to learn more. Always consult a physician before changes.
Type: Cholinesterase Inhibitor
Prevents the breakdown of acetylcholine, a chemical important for memory and learning.
Type: Cholinesterase Inhibitor
Blocks enzymes that break down acetylcholine. Available as a patch or capsule.
Type: Cholinesterase Inhibitor
Enhances acetylcholine activity and modulates nicotinic receptors in the brain.
Type: NMDA Receptor Antagonist
Regulates glutamate activity to protect brain cells from excess stimulation.
Type: Combination Therapy
Combines the benefits of both a cholinesterase inhibitor and NMDA receptor antagonist.
Type: Anti-Amyloid Antibody
Targets and removes amyloid beta plaques to slow disease progression. Requires regular MRI monitoring.
Type: Anti-Amyloid Antibody
Targets a modified form of amyloid plaque. May allow patients to discontinue after plaque clearance.
Click any term to see its definition.
Articles and reflections from Dr. Sherry L. Perry on caregiving, research, and community resilience.
Exploring the complex interplay of genetics, cardiovascular risk, socioeconomic factors, and systemic racism that drives disparities — and the community-led solutions making a difference.
More than 12 million Americans provide unpaid care for loved ones with Alzheimer's. Learn to recognize the warning signs of burnout and protect your own well-being.
For the first time, FDA-approved therapies can slow the progression of early-stage Alzheimer's. Learn how anti-amyloid antibodies work and what these breakthroughs mean.
Educational video content by Dr. Sherry L. Perry, PhD — supporting caregivers and families at every stage.
Navigating emotions, next steps, and building a care team after a loved one receives an Alzheimer's diagnosis.
Strategies for responding to agitation, wandering, repetitive questions, and other common behavioral symptoms.
Techniques for managing stress, preventing burnout, and maintaining your own physical and emotional health.
Tools designed by Dr. Perry to empower caregivers and families navigating dementia.
Stage-by-stage roadmaps, daily routines, behavioral frameworks, and caregiver wellness tools.
Buy NowDaily mood and behavior logging, medication tracking, and caregiving milestone records.
Buy Now
Daily health logging, legal and financial prep tools, and complete caregiver wellness tracking.
Buy Now